US Patent 7381731 Pharmaceutical composition comprising citrulline
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Wayne H. Kaesemeyer0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+272 characters)
Article
Patent abstract
Embodiments of the present invention include compositions and pharmaceutical compositions comprising citrulline and Hmg-CoA reductase inhibitors. Further embodiments relate to the use of such composition treat subjects and stimulating nitric oxide synthase.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07381731 Pharmaceutical composition comprising citrulline US Patent 7381731 Pharmaceutical composition comprising citrulline
Infobox
Patent Number
073817310
Patent Number
73817310
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073817310
Date of Patent
June 3, 2008
0Patent Application Number
107633090
Date Filed
January 23, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07381731 Pharmaceutical composition comprising citrulline
Infobox
Is a
Patent jurisdiction
Patent number
07381731
Date of patent
June 3, 2008
Patent application number
10763309
Date Filed
January 23, 2004
Patent primary examiner
Find more entities like US Patent 7381731 Pharmaceutical composition comprising citrulline
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
